Atogepant has demonstrated efficacy in reducing the frequency and severity of migraines in various clinical studies. While it may be effective for many individuals with migraines, the response to atogepant can vary depending on various factors, including the specific type of migraine. Migraines can manifest in different ways, such as with or without aura, and can have varying underlying mechanisms. Therefore, it is important for patients to consult with their healthcare provider to determine whether atogepant is an appropriate treatment option for their specific type of migraine. A personalized approach to migraine management, considering individual characteristics and factors, will help optimize treatment outcomes.